Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia

被引：23

作者：

Ribeiro da Matta, Vania Lucia

Melhem, Marcia de Souza Carvalho

Colombo, Arnaldo Lopes

Moretti, Maria Luiza

Rodero, Laura

Duboc de Almeida, Gisele Madeira

Martins, Marilena dos Anjos

Costa, Silvia Figueiredo

Dias, Maria Beatriz G. Souza

Nucci, Marcio

Levin, Anna S.

机构：

[1] Adolfo Lutz Inst, Sao Paulo, Brazil

[2] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil

[3] Univ Estadual Campinas, Fac Med Sci, Div Infect Dis, Campinas, SP, Brazil

[4] Univ Catolica Argentina, Fac Med, Buenos Aires, DF, Argentina

[5] Univ Sao Paulo, Hosp Clin, Lab Clin Micorbiol, Sao Paulo, Brazil

[6] Univ Sao Paulo, Hosp Clin, Hosp Infect Control Dept, LIM 54, Sao Paulo, Brazil

[7] Hosp Sirio Libanes, Sao Paulo, Brazil

[8] Univ Fed Rio de Janeiro, Dept Internal Med, Rio De Janeiro, Brazil

[9] Univ Sao Paulo, Hosp Clin, Dept Infect Dis, Sao Paulo, Brazil

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 04期

关键词：

D O I：

10.1128/AAC.01038-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

In vitro susceptibility of 58 isolates of Pichia anomala to five antifungal drugs using two broth microdilution methods (CLSI and EUCAST) was analyzed. Low susceptibility to itraconazole was observed. Fluconazole, voriconazole, amphotericin B, and caspofungin showed good antifungal activity, although relatively high drug concentrations were necessary to inhibit the isolates.

引用

收藏

页码：1573 / 1576

页数：4

相关论文

共 43 条

[1] DEVELOPMENT OF HANSENULA-ANOMALA INFECTION IN A CHILD RECEIVING FLUCONAZOLE THERAPY [J].

ALTER, SJ ;

FARLEY, J .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (02) :158-159

[2] Pichia anomala outbreak in a nursery:: exogenous source? [J].

Aragao, PA ;

Oshiro, ICV ;

Manrique, EI ;

Gomes, CC ;

Matsuo, LL ;

Leone, C ;

Moretti-Branchini, ML ;

Levin, AS .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (09) :843-848

[3] Pichia anomala fungaemia in immunocompromised children [J].

Bakir, M ;

Çerikcioglu, N ;

Tirtir, A ;

Berrak, S ;

Özek, E ;

Canpolat, C .

MYCOSES, 2004, 47 (5-6) :231-235

[4] Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates [J].

Barchiesi, F ;

Tortorano, AM ;

Di Francesco, LF ;

Rigoni, A ;

Giacometti, A ;

Spreghini, E ;

Scalise, G ;

Viviani, MA .

JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (03) :279-285

[5] In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp. [J].

Barchiesi, F ;

Tortorano, AM ;

Di Francesco, LF ;

Cogliati, M ;

Scalise, G ;

Viviani, MA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) :295-299

[6] Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India [J].

Chakrabarti, A ;

Singh, K ;

Narang, A ;

Singhi, S ;

Batra, R ;

Rao, KLN ;

Ray, P ;

Gopalan, S ;

Das, S ;

Gupta, V ;

Gupta, AK ;

Bose, SM ;

McNeil, MM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (05) :1702-1706

[7] Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species [J].

Chryssanthou, E ;

Cuenca-Estrella, M .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) :3841-3844

[8] Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals [J].

Colombo, AL ;

Nakagawa, Z ;

Valdetaro, F ;

Branchini, MLM ;

Kussano, EJU ;

Nucci, M .

MEDICAL MYCOLOGY, 2003, 41 (03) :235-239

[9] Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain [J].

Cuenca-Estrella, M ;

Díaz-Guerra, TM ;

Mellado, E ;

Monzón, A ;

Rodríguez-Tudela, JL .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) :432-435

[10] Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species [J].

Cuenca-Estrella, M ;

Lee-Yang, W ;

Ciblak, MA ;

Arthington-Skaggs, BA ;

Mellado, E ;

Warnock, DW ;

Rodriguez-Tudela, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3644-3647

← 1 2 3 4 5 →